Tony Goodman
Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsAbout Tony Goodman
Tony Goodman is recorded as COO at Azora Therapeutics, Inc. (DE) (AZR) since April 1, 2025. Azora Therapeutics, Inc. (DE) reported in an 8-K filed June 11, 2026 that Tony Goodman resigned as Class I Director, effective June 11, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed March 21, 2025 that Tony Goodman was appointed Chief Operating Officer, effective April 1, 2025. Azora Therapeutics, Inc. (DE) reported in an 8-K filed January 18, 2024 that Tony Goodman was appointed Chief Operating Officer, effective January 17, 2024. The proxy statement of Azora Therapeutics, Inc. (DE) reports total compensation of $469,967 for Tony Goodman in fiscal 2025, including a base salary of $300,000. Disclosed compensation is on record for 3 fiscal years. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.
“In connection with the Merger, effective as of the First Effective Time, Tony Goodman resigned as a Class I Director of the Company.”
“On March 20, 2025, Adial Pharmaceuticals, Inc. (the "Company") entered into an employment agreement with Tony Goodman (the "Goodman Employment Agreement") to employ Mr. Goodman as the Company's Chief Operating Officer for a three-year term effective April 1, 2025 (the "Effective Date") at an annual base salary of $300,000, with a discretionary bonus of up to 30% of his base salary upon achievement of objectives as may be determined by the Company's board of directors.”
Affiliation history
-
Current
2025-04-01–present
-
2025-04-01–2026-06-11
-
2017-01-01–2026-06-11
Company network
Leadership on record at Azora Therapeutics, Inc. (DE)
- Matthew Davidson CEO
- Matthew Davidson, Ph.D. CEO
- William B. Stilley CEO
- Kevin Schuyler Chairman
- Celia Economides CFO
- Vinay K. Shah CFO
- Cary Claiborne COO, Board Member
- Cary J. Claiborne COO, Board Member
- Dr. Jack Reich Board Member
- Matt Davidson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Operating Officer | $300,000 | $469,967 |
| 2024 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Operating Officer | $298,500 | $376,198 |
| 2023 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Operating Officer | — | $258,932 |